Zydus Therapeutics’ PBC data: The drug saroglitazar met the primary endpoint in a Phase 2b/3 trial for a rare autoimmune disease that affects the bile ducts, the …
Author: PharmaSignal News Desk
CVS Health will not add Gilead Sciences’ new HIV prevention drug to its commercial plans for now, despite the medicine’s proven effectiveness
The vaccine is approved for adults aged 65 years and older and individuals aged 5 to 64 years with underlying conditions
The authorised generic of Carac (fluorouracil cream) 0.5 per cent is approved by the USFDA and manufactured in Texas for the treatment of actinic keratoses
India’s pharmaceutical industry is advancing from bulk drug production to complex formulations, strengthening its role in the global healthcare ecosystem
Concerns are mounting in India over the UK-India Free Trade Agreement’s potential impact on access to affordable medicines. Experts fear the deal may weaken compulsory licensing norms, a crucial safeguard allowing generic drug production during public health emergencies
Alembic Pharmaceuticals receives USFDA approval for Tretinoin Cream USP (0.025%). • The cream is therapeutically equivalent to Bausch Health’s Retin-A Cream. •
Aurobindo Pharma invested USD 145 million in its China facility. • The plant commenced operations in November 2024. • Break-even at EBITDA level is expected by
Mounjaro priced from Rs 14,000 for weekly administration. • Offers six dose strengths for personalized treatment. • Targets type 2 diabetes and obesity manageme
Lupin partners with Sandoz for biosimilar ranibizumab commercialization. • Sandoz handles commercialization in multiple regions, excluding Germany. • Lupin will